SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alivus Life Sciences informs about newspaper advertisement

12 Aug 2025 Evaluate

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Alivus Life Sciences has informed that it enclosed copies of newspaper advertisement published in Financial Express (English) all India edition and Loksatta (Marathi) today on August 12, 2025 informing the Members about the 14th Annual General Meeting scheduled to be held on Monday, September 08, 2025 at 3:00 pm IST through Video Conferencing (VC) / Other Audio Visual Means (OAVM), E-voting and manner of registering email address etc.

The above information is a part of company’s filings submitted to BSE.


Alivus Life Sciences Share Price

1046.50 3.30 (0.32%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×